Search Results

You are looking at 141 - 150 of 381 items for :

  • "early detection" x
  • Refine by Access: Content accessible to Me x
Clear All
Full access

Impact of an NCCN-Compliant Multidisciplinary Conference on Treatment Decisions for Localized Prostate Cancer

Ahmed A. Hussein, Umar Iqbal, Zhe Jing, Yousuf Ramahi, Holly Houenstein, Stephanie Newman, Blake Peterson, Katarina Krajacic, Adeena Samoni, Bo Xu, Norbert Sule, Gissou Azabdaftari, Eric C. Kauffman, James L. Mohler, Michael Kuettel, and Khurshid A. Guru

world. The NCCN Guidelines for Prostate Cancer 4 and for Prostate Cancer Early Detection 5 provide recommendations for early detection, evaluation, and treatment that seek to avoid overdiagnosis and overtreatment. Compliance with treatment guidelines

Full access

Advancing More Equitable Care Through the Development of a Health Equity Report Card

Alyssa A. Schatz, Shonta Chambers, Gretchen C. Wartman, Lisa A. Lacasse, Crystal S. Denlinger, Kristen M. Hobbs, Lindsey Bandini, Robert W. Carlson, and Robert A. Winn

of guideline-concordant care. Following these presentations, the working group members were assigned to small discussion groups across 4 key focus areas: (1) research and clinical trials, (2) risk reduction, prevention, and early detection, (3) care

Full access

Prostate Cancer, Version 2.2014

James L. Mohler, Philip W. Kantoff, Andrew J. Armstrong, Robert R. Bahnson, Michael Cohen, Anthony Victor D’Amico, James A. Eastham, Charles A. Enke, Thomas A. Farrington, Celestia S. Higano, Eric Mark Horwitz, Christopher J. Kane, Mark H. Kawachi, Michael Kuettel, Timothy M. Kuzel, Richard J. Lee, Arnold W. Malcolm, David Miller, Elizabeth R. Plimack, Julio M. Pow-Sang, David Raben, Sylvia Richey, Mack Roach III, Eric Rohren, Stan Rosenfeld, Edward Schaeffer, Eric J. Small, Guru Sonpavde, Sandy Srinivas, Cy Stein, Seth A. Strope, Jonathan Tward, Dorothy A. Shead, and Maria Ho

for 29,480 deaths in 2014. 1 This comparatively low death rate suggests that, unless prostate cancer is becoming biologically less aggressive, increased public awareness with earlier detection and treatment has begun to affect mortality from this

Full access

Non-Hodgkin’s Lymphomas, Version 3.2012

Andrew D. Zelenetz, William G. Wierda, Jeremy S. Abramson, Ranjana H. Advani, C. Babis Andreadis, Nancy Bartlett, Naresh Bellam, John C. Byrd, Myron S. Czuczman, Luis Fayad, Martha J. Glenn, Jon P. Gockerman, Leo I. Gordon, Nancy Lee Harris, Richard T. Hoppe, Steven M. Horwitz, Christopher R. Kelsey, Youn H. Kim, Susan Krivacic, Ann S. LaCasce, Auayporn Nademanee, Pierluigi Porcu, Oliver Press, Barbara Pro, Nishitha Reddy, Lubomir Sokol, Lode Swinnen, Christina Tsien, Julie M. Vose, Joachim Yahalom, Nadeem Zafar, Maoko Naganuma, and Mary A. Dwyer

detected clinically at the same time as PET. Whether this earlier detection of relapse in a proportion of patients translates to improved outcomes is unclear. Diffuse Large B-Cell Lymphoma Considerable debate remains in the routine use of follow

Full access

Guideline Familiarity Predicts Variation in Self-Reported Use of Routine Surveillance PET/CT by Physicians Who Treat Head and Neck Cancer

Benjamin R. Roman, Snehal G. Patel, Marilene B. Wang, Anna M. Pou, F. Christopher Holsinger, David Myssiorek, David Goldenberg, Samuel Swisher-McClure, Alexander Lin, Jatin P. Shah, and Judy A. Shea

recurrence or second primary lesions in the treated head and neck cancer patient . Laryngoscope 2013 ; 123 : 2161 – 2164 . 32. Kostakoglu L Fardanesh R Posner M . Early detection of recurrent disease by FDG-PET/CT leads to management changes in

Full access

Treatment Patterns and Survival Outcomes in Patients With Breast Cancer on Medicaid, Pre- and Post-Expansion

Siran M. Koroukian, Weichuan Dong, Jeffrey M. Albert, Uriel Kim, Kirsten Eom, Johnie Rose, Cynthia Owusu, Kristine M. Zanotti, Gregory Cooper, and Jennifer Tsui

of diagnosis. We excluded women who joined Medicaid through the Ohio Breast and Cervical Cancer Early Detection Program or with missing data on treatment modalities (n=2,833; see Figure S1 in the supplementary materials , available online with this

Full access

Cancer Survivorship: We’ve Only Just Begun

Mary S. McCabe

Over the past decade, tremendous progress has been made in the early detection and effective treatment of many cancers, resulting in a growing population of cancer survivors in the United States that exceeds 13.7 million as of 2012. 1 With the 5

Full access

Ambulatory Oncology Operations: Strategies to Alleviate Complexity

Chadi Nabhan and Sandeep Parsad

of increased demand. 3 Factors Affecting Outpatient Delivery of Cancer Care In addition to a growing population of patients with cancer as a result of advances in earlier detection and the success of prolonged survival, the economy, new

Full access

Evidence and Insights in the NCCN Guidelines

Joan S. McClure

sometimes even contentious. The sheer volume of data that must be considered for a guideline that covers the continuum of care from diagnosis through palliation or addressing the issues relating to screening and early detection for a given disease is

Full access

Electronic Clinical Decision Tools for Improving Adherence to Colon Cancer Surveillance Guidelines: Can the Chips Finally Fall Into Place?

Shajan Peter

Colorectal cancer (CRC) remains the fourth most frequently diagnosed cancer and second leading cause of cancer death in the United States. 1 Screening of average-risk individuals reduces mortality through early detection and removal of polyps. 2